by jlohrconsulting | Oct 23, 2025 | Uncategorized
J Psychiatr Res. 2025 Sep 27;191:798-808. doi: 10.1016/j.jpsychires.2025.09.070. Online ahead of print. ABSTRACT Currently, placebo-controlled clinical trials report mean change and effect sizes, which masks information about heterogeneity of treatment effects (HTE)....
by jlohrconsulting | Oct 23, 2025 | Uncategorized
BJPsych Open. 2025 Oct 23;11(6):e250. doi: 10.1192/bjo.2025.10872. ABSTRACT BACKGROUND: Depression is the most common psychiatric disorder among patients with end-stage renal disease (ESRD), yet the risk factors for mortality in this population remain unclear. AIMS:...
by jlohrconsulting | Oct 23, 2025 | Uncategorized
Br J Psychiatry. 2025 Oct 23:1-8. doi: 10.1192/bjp.2025.10427. Online ahead of print. ABSTRACT BACKGROUND: The association between geriatric depression and out-of-hospital cardiac arrest (OHCA) has not been fully clarified. AIMS: This study aimed to develop and...
by jlohrconsulting | Oct 23, 2025 | Uncategorized
Qual Life Res. 2025 Oct 23. doi: 10.1007/s11136-025-04089-5. Online ahead of print. ABSTRACT PURPOSE: To derive the first population norms from the EQ-5D-5L in Iran during the COVID-19 pandemic. METHODS: Data were obtained from a study conducted in Iran during the...
by jlohrconsulting | Oct 23, 2025 | Uncategorized
Qual Life Res. 2025 Oct 23. doi: 10.1007/s11136-025-04082-y. Online ahead of print. ABSTRACT PURPOSE: To examine whether ratings on each of the five dimensions of the EQ-5D-5L vary across ethnic groups after adjusting for health conditions and other relevant...
Recent Comments